Improving the Vision and Quality of Life of all People with Diabetic Retinal Disease 

Retina Care International
Read More

What we do

Retina Care International is an American based, not-for-profit, 501(c)3 organization that is committed to improving the quality of life of all people with diabetic retinal disease around the world.
Read More

We Find & Fund

We have recently partnered with AIHWA, American Initiative for Health and Wellness in Africa, and are co-funding the construction and outfitting of a stand alone ophthalmology clinic in Owerri, Imo State, Nigeria.

We Provide Care

We are currently travelling to the cities of Tizimin, Ticul and Merida, in the Yucatan Peninsula of Mexico as well as to the Imo State, Nigeria conducting Diabetic Retinopathy Screening Campaigns that lead to the identification and treatment of blinding retinopathy.

The numbers speak for themselves

Dating back to the inaugural diabetic retinopathy screening campaign in Yucatan, Mexico in 2005, Retina Care International’s teams have screened in excess of 6,100 patients with diabetes mellitus and have treated over a 1000 patients with laser photocoagulation and vitrectomy surgeries.

463 Million

People living with diabetes worldwide today

700 Million

People projected to have diabetes worldwide by 2045

28.5 Million

People affected with sight-threatening Diabetic Retinopathy worldwide

6,426

People with diabetes screened by Retina Care International for Diabetic Retinopathy in Yucatan, Mexico and Imo State, Nigeria since 2005

  • Photo 1: Local ophthalmologist from Mexico using argon laser photocoagulation surgery on a patient with diabetic retinopathy.
  • Photo 2: local Nigerian ophthalmologists performing argon laser photocoagulation surgery on a patient with diabetic retinopathy. The doctors were trained by Dr. Wroblewski and the $90,000 laser was donated by Retina Care International.
  • Photos 3: local Nigerian optometrists using portable Fundus on Phone cameras with Artificial Intelligence software to screen diabetic patients for blinding retinopathy.